Abstract
Osteosarcoma is a bone tumour that most often affects children and young adults. Although a combination of surgery to remove the primary tumour and chemotherapy prior to and after the surgery has led to an improved survival rate, local recurrence and metastases still develop in two-fifths of patients. A definitive therapy is yet to be determined for this deadly disease. This article discusses the current status on diagnosis and treatment, with an emphasis on developing new molecularly targeted therapies.
Original language | English (US) |
---|---|
Pages (from-to) | 18-23 |
Number of pages | 6 |
Journal | European Musculoskeletal Review |
Volume | 6 |
Issue number | 1 |
State | Published - Feb 1 2011 |
Keywords
- 2-methoxyestradiol
- Bone tumour
- Chemotherapy
- Osteosarcoma
- Sarcoma
- Tumour surgery
ASJC Scopus subject areas
- Orthopedics and Sports Medicine